In ovarian cancer, activated EGFR upregulates MMP-9 which sequentially promotes the degradation of E-cadherin molecules resulting in metastasis (Cowden Dahl et al., 2008; Alshenawy, 2010). This evidence concerns the gene MMP9 and ovarian carcinoma.